Broxaterol - Zambon Group SpA
Alternative Names: Arebrox; Summair; Z 1170Latest Information Update: 15 Jun 1995
At a glance
- Originator Zambon Group SpA
- Developer Zambon Company SpA
- Class Bronchodilators
- Mechanism of Action Beta 2 adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Registered Asthma
Most Recent Events
- 15 Jun 1995 Discontinued-II for Asthma in Sweden (PO)
- 15 Jun 1995 Discontinued-III for Asthma in Belgium (PO)
- 15 Jun 1995 Discontinued-III for Asthma in France (PO)